World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
34559
World Ranking
19266
National Ranking
9597

Edmund J. Lewis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edmund J. Lewis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 216 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edmund J. Lewis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edmund J. Lewis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edmund J. Lewis is affiliated with Rush University Medical Center in the United States. Their research primarily focuses on the field of medicine, with a particular emphasis on cardiology and cardiovascular medicine. Other subfields include endocrinology, diabetes and metabolism, cancer research, neurology, and developmental neuroscience.

The scientist's work covers a range of topics related to cardiovascular health and associated physiological mechanisms. Main topics of their research include:

  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Hormonal Regulation and Hypertension
  • Cardiac Health and Mental Health
  • Cancer, Lipids, and Metabolism
  • Neuroinflammation and Neurodegeneration Mechanisms
  • MicroRNA in disease regulation

Edmund J. Lewis has contributed to publications in various prominent venues, including:

  • The Lancet (2 publications)
  • The Lancet Oncology (1 publication)
  • The Lancet Diabetes & Endocrinology (1 publication)
  • Cell Reports (1 publication)
  • European Heart Journal (1 publication)

Notable recent papers authored or co-authored by Lewis include:

  • "Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis," 2021, The Lancet
  • "Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis," 2021, The Lancet
  • "Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis," 2021, The Lancet Oncology
  • "Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis," 2022, The Lancet Diabetes & Endocrinology
  • "Defining the molecular identity and morphology of glia limitans superficialis astrocytes in vertebrates," 2025, Cell Reports

Frequent collaborators of Edmund J. Lewis comprise several researchers with whom they have co-authored multiple publications. These include Mark Woodward, Sverre E. Kjeldsen, John Chalmers, Barry R. Davis, and Kazem Rahimi.

Best Publications

  • The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group

    E J Lewis;L G Hunsicker;R P Bain;R D Rohde

  • The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

    Edmund J. Lewis;Lawrence G. Hunsicker;Raymond P. Bain;Richard D Rohde

  • Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

    Hans-Henrik Parving;Frederik Persson;Julia B. Lewis;Edmund J. Lewis

  • A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

    Edmund J. Lewis;Lawrence G. Hunsicker;Shu-Ping Lan;Richard D. Rohde

  • GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

    Andrew S. Levey;Lesley A. Inker;Kunihiro Matsushita;Tom H Greene

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations

    Marc A. Pohl;Samuel Blumenthal;Daniel J. Cordonnier;Fernando De Alvaro

  • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy

    Tomas Berl;Lawrence G. Hunsicker;Julia B. Lewis;Marc A. Pfeffer

  • Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

    Robert C. Atkins;Esther M. Briganti;Julia B. Lewis;Lawrence G. Hunsicker

  • Factors predictive of outcome in severe lupus nephritis

    Stephen M. Korbet;Edmund J. Lewis;Melvin M. Schwartz;Morris Reichlin

  • Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial

    Tomas Berl;Lawrence G. Hunsicker;Julia B. Lewis;Marc A. Pfeffer

  • Glomerulopathies of neoplasia.

    Jeremiah W. Eagen;Edmund J. Lewis

  • Severe Lupus Nephritis: Racial Differences in Presentation and Outcome

    Stephen M. Korbet;Melvin M. Schwartz;Joni Evans;Edmund J. Lewis

  • Primary Focal Segmental Glomerulosclerosis: Clinical Course and Response to Therapy

    Stephen M. Korbet;Melvin M. Schwartz;Edmund J. Lewis

  • Value of a complete or partial remission in severe lupus nephritis.

    Yiann E. Chen;Stephen M. Korbet;Robert S. Katz;Melvin M. Schwartz

  • Pulmonary hemorrhage in systemic lupus erythematosus.

    Jeremiah W. Eagen;Vincent A. Memoli;Jimmy L. Roberts;Guy R. Matthew

  • Focal Segmental Glomerulosclerosis in Nephrotic Adults: Presentation, Prognosis, and Response to Therapy of the Histologic Variants

    Micky J Chun;Stephen M Korbet;Melvin M Schwartz;Edmund J Lewis

  • Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis

    Christopher C. Najafi;Christopher C. Najafi;Stephen M. Korbet;Stephen M. Korbet;Edmund J. Lewis;Edmund J. Lewis;Melvin M. Schwartz;Melvin M. Schwartz

  • Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

    Julia A. Breyer;Raymond P. Bain;Joni K. Evans;N. Stanley Nahman

  • Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    Hiddo J L Heerspink;Tom Greene;Hocine Tighiouart;Hocine Tighiouart;Ron T Gansevoort

Frequent Co-Authors

John M. Lachin
John M. Lachin George Washington University
Andrew S. Levey
Andrew S. Levey Tufts Medical Center
Norman K. Hollenberg
Norman K. Hollenberg Brigham and Women's Hospital
Dick de Zeeuw
Dick de Zeeuw University of Groningen
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
Hans-Henrik Parving
Hans-Henrik Parving University of Copenhagen
Samuel Z. Goldhaber
Samuel Z. Goldhaber Brigham and Women's Hospital
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Francesco Locatelli
Francesco Locatelli University of Pavia
Peter H. Schur
Peter H. Schur Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up various online degree options that can help you enter or advance in the healthcare field. For those interested in nursing, lpn programs offer a fast-track way to start working as a Licensed Practical Nurse, making them ideal for students looking for a quicker entry into patient care.

If your interest lies in mental health, you might consider the shortest post master's pmhnp online programs to become a Psychiatric Mental Health Nurse Practitioner. These accelerated programs are perfect for registered nurses seeking specialty credentials in psychiatric care.

For those drawn to the administrative side of healthcare, there are many options to study management online. Pursuing an affordable healthcare administration degree online allows you to start or advance your career in hospital and clinic leadership roles without excessive tuition costs.

If you’re looking to take your qualifications further, consider some of the cheapest master's in healthcare administration programs. These master’s degrees can open doors to senior healthcare management positions and broaden your impact in the industry.

Best Scientists Citing Edmund J. Lewis

Trending Scientists

Recently Published Articles